A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects

J. S. Lakind, S. T. Holgate, Dennis Randall Ownby, A. H. Mansur, P. J. Helms, D. Pyatt, S. M. Hays

Research output: Contribution to journalReview article

82 Citations (Scopus)

Abstract

Biomarkers associated with asthma aetiology and exacerbation have been sought to shed light on this multifactorial disease. One candidate is the serum concentration of the Clara cell secretory protein (CC16, sometimes referred to as CC10 or uteroglobin). In this review, we examine serum CC16's relation to asthma aetiology and exacerbation. There is evidence that acute exposures to certain pulmonary irritants can cause a transient increase in serum CC16 levels, and limited evidence also suggests that a transient increase in serum CC16 levels can be caused by a localized pulmonary inflammation. Research also indicates that a transient increase in serum CC16 is not associated with measurable pulmonary damage or impairment of pulmonary function. The biological interpretation of chronic changes in serum CC16 is less clear. Changes in serum CC16 concentrations (either transient or chronic) are not specific to any one agent, disease state, or aetiology. This lack of specificity limits the use of serum CC16 as a biomarker of specific exposures. To date, many of the critical issues that must be understood before serum CC16 levels can have an application as a biomarker of effect or exposure have not been adequately addressed.

Original languageEnglish (US)
Pages (from-to)445-467
Number of pages23
JournalBiomarkers
Volume12
Issue number5
DOIs
StatePublished - Sep 1 2007

Fingerprint

Uteroglobin
Biomarkers
Lung
Serum
Irritants
Asthma
Pneumonia

Keywords

  • Asthma
  • Biomarker
  • CC10
  • CC16
  • Clara cell secretory protein
  • Environmental exposures

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. / Lakind, J. S.; Holgate, S. T.; Ownby, Dennis Randall; Mansur, A. H.; Helms, P. J.; Pyatt, D.; Hays, S. M.

In: Biomarkers, Vol. 12, No. 5, 01.09.2007, p. 445-467.

Research output: Contribution to journalReview article

Lakind, J. S. ; Holgate, S. T. ; Ownby, Dennis Randall ; Mansur, A. H. ; Helms, P. J. ; Pyatt, D. ; Hays, S. M. / A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. In: Biomarkers. 2007 ; Vol. 12, No. 5. pp. 445-467.
@article{234678bbec8549dd8d31346b826d5181,
title = "A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects",
abstract = "Biomarkers associated with asthma aetiology and exacerbation have been sought to shed light on this multifactorial disease. One candidate is the serum concentration of the Clara cell secretory protein (CC16, sometimes referred to as CC10 or uteroglobin). In this review, we examine serum CC16's relation to asthma aetiology and exacerbation. There is evidence that acute exposures to certain pulmonary irritants can cause a transient increase in serum CC16 levels, and limited evidence also suggests that a transient increase in serum CC16 levels can be caused by a localized pulmonary inflammation. Research also indicates that a transient increase in serum CC16 is not associated with measurable pulmonary damage or impairment of pulmonary function. The biological interpretation of chronic changes in serum CC16 is less clear. Changes in serum CC16 concentrations (either transient or chronic) are not specific to any one agent, disease state, or aetiology. This lack of specificity limits the use of serum CC16 as a biomarker of specific exposures. To date, many of the critical issues that must be understood before serum CC16 levels can have an application as a biomarker of effect or exposure have not been adequately addressed.",
keywords = "Asthma, Biomarker, CC10, CC16, Clara cell secretory protein, Environmental exposures",
author = "Lakind, {J. S.} and Holgate, {S. T.} and Ownby, {Dennis Randall} and Mansur, {A. H.} and Helms, {P. J.} and D. Pyatt and Hays, {S. M.}",
year = "2007",
month = "9",
day = "1",
doi = "10.1080/13547500701359327",
language = "English (US)",
volume = "12",
pages = "445--467",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects

AU - Lakind, J. S.

AU - Holgate, S. T.

AU - Ownby, Dennis Randall

AU - Mansur, A. H.

AU - Helms, P. J.

AU - Pyatt, D.

AU - Hays, S. M.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Biomarkers associated with asthma aetiology and exacerbation have been sought to shed light on this multifactorial disease. One candidate is the serum concentration of the Clara cell secretory protein (CC16, sometimes referred to as CC10 or uteroglobin). In this review, we examine serum CC16's relation to asthma aetiology and exacerbation. There is evidence that acute exposures to certain pulmonary irritants can cause a transient increase in serum CC16 levels, and limited evidence also suggests that a transient increase in serum CC16 levels can be caused by a localized pulmonary inflammation. Research also indicates that a transient increase in serum CC16 is not associated with measurable pulmonary damage or impairment of pulmonary function. The biological interpretation of chronic changes in serum CC16 is less clear. Changes in serum CC16 concentrations (either transient or chronic) are not specific to any one agent, disease state, or aetiology. This lack of specificity limits the use of serum CC16 as a biomarker of specific exposures. To date, many of the critical issues that must be understood before serum CC16 levels can have an application as a biomarker of effect or exposure have not been adequately addressed.

AB - Biomarkers associated with asthma aetiology and exacerbation have been sought to shed light on this multifactorial disease. One candidate is the serum concentration of the Clara cell secretory protein (CC16, sometimes referred to as CC10 or uteroglobin). In this review, we examine serum CC16's relation to asthma aetiology and exacerbation. There is evidence that acute exposures to certain pulmonary irritants can cause a transient increase in serum CC16 levels, and limited evidence also suggests that a transient increase in serum CC16 levels can be caused by a localized pulmonary inflammation. Research also indicates that a transient increase in serum CC16 is not associated with measurable pulmonary damage or impairment of pulmonary function. The biological interpretation of chronic changes in serum CC16 is less clear. Changes in serum CC16 concentrations (either transient or chronic) are not specific to any one agent, disease state, or aetiology. This lack of specificity limits the use of serum CC16 as a biomarker of specific exposures. To date, many of the critical issues that must be understood before serum CC16 levels can have an application as a biomarker of effect or exposure have not been adequately addressed.

KW - Asthma

KW - Biomarker

KW - CC10

KW - CC16

KW - Clara cell secretory protein

KW - Environmental exposures

UR - http://www.scopus.com/inward/record.url?scp=34548164824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548164824&partnerID=8YFLogxK

U2 - 10.1080/13547500701359327

DO - 10.1080/13547500701359327

M3 - Review article

VL - 12

SP - 445

EP - 467

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 5

ER -